• Citer

Immunogenicity of an adjuvanted SARS-CoV-2 trimeric S-protein subunit vaccine (SCB-2019) in SARS-CoV-2-naïve and exposed individuals in a phase 2/3, double-blind, randomized study

par Buntinx, Erik;Brochado, Leonardo;Borja-Tabora, Charissa;Yu, Charles Y.;Alberto, Edison R;Montellano, May Emmeline;Carlos, Josefina C.;Toloza, Leonardo Bautista;Hites, Maya ;Siber, George;Clemens, Ralf;Ambrosino, Donna;Qin, Haijing;Chen, Hui Ling;Han, Htay Htay;Hu, Branda;Li, Ping;Baccarini, Carmen;Smolenov, Igor
Référence Vaccine
Publication Publié, 2023-02-01

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Immunogenicity of an adjuvanted SARS-CoV-2 trimeric S-protein subunit vaccine (SCB-2019) in SARS-CoV-2-naïve and exposed individuals in a phase 2/3, double-blind, randomized study
Auteur:	Buntinx, Erik; Brochado, Leonardo; Borja-Tabora, Charissa; Yu, Charles Y.; Alberto, Edison R; Montellano, May Emmeline; Carlos, Josefina C.; Toloza, Leonardo Bautista; Hites, Maya; Siber, George; Clemens, Ralf; Ambrosino, Donna; Qin, Haijing; Chen, Hui Ling; Han, Htay Htay; Hu, Branda; Li, Ping; Baccarini, Carmen; Smolenov, Igor
Informations sur la publication:	Vaccine
Statut de publication:	Publié, 2023-02-01
Sujet CREF:	Immunologie
Mots-clés:	Cell-mediated immunity
	COVID-19
	Immunogenicity
	SARS-CoV-2
	SCB-2019
	Vaccine
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0264-410X
	info:doi/10.1016/j.vaccine.2023.02.017
	info:pii/S0264410X23001433
	info:scp/85149200519
	info:pmid/36781334